Case study · Colorectal cancer

A scalable at-home
FIT program for health plans.

How early campaign initiation, sustained multi-touch outreach, and real-time performance monitoring turned an at-home colorectal cancer screening program into measurable clinical and financial value for a regional health plan.

An at-home colorectal cancer FIT screening kit
5,000

FIT kits mailed to eligible members

1,205

Completed screenings returned

24%

Overall return rate, well above program norms

19

Members who had polyps removed early

Overview

Preventive screening that pays off clinically and financially.

Preventive screening is one of the few healthcare investments that can improve population health, strengthen quality performance, and lower long-term cost all at once. The value comes from strong participation, predictable execution, and steady, well-paced spending, which is exactly what this program was built to deliver.

SNT Biotech delivered an at-home colorectal cancer screening program using FIT (Fecal Immunochemical Test) kits for a regional health plan. The program identified 5,000 eligible members and ran from August through December, a full five months of engagement runway that gave members ample time to respond and the program room to keep improving.

How it was built

Program design

Opt-out enrollment

A pre-kit notification letter explained the program and gave every member a clear option to opt out. Kits shipped automatically to those who did not, enabling earlier starts and higher completion.

💬

Multi-touch outreach

Each member received roughly 4 automated calls, 5 or more SMS reminders, up to 2 live outreach attempts, and a replacement kit when needed, distributed across the full campaign.

📊

Operational controls

Address validation, a controlled mailing cadence, and real-time dashboards let us optimize outreach continuously from live performance data, improving results throughout the campaign.

Results

Measurable outcomes at scale.

Metric Result
FIT kits mailed5,000
Completed screenings returned1,205
Overall return rate24%
Abnormal results identified121 (~10%)
Members who had polyps removed19
Campaign durationAugust to December
Clinical impact

From screening to care, we close the loop.

Among the 1,205 completed screenings, 121 tests (about 10%) produced abnormal results requiring further clinical evaluation. Every member with an abnormal finding was referred for diagnostic follow-up in accordance with established clinical guidelines and health plan protocols.

As a result, 19 members had polyps removed early, a preventive intervention that catches risk at its most treatable stage. From a population health perspective, that shifts care earlier in the continuum, where treatment costs are lower, outcomes are stronger, and long-term value is greater.

Why timing matters

Start early, spend smarter.

Time is a controllable variable that materially affects return on investment. Starting early distributes outreach over a longer window, lifts utilization without a proportional increase in spend, reduces operational volatility late in the year, and lowers cost per completed screening.

By starting in August, the program spread engagement across five months, kept operations steady, and prioritized predictable, high-value execution, so every dollar worked harder toward completed screenings.

An SNT Biotech scientist operating a diagnostic analyzer
Aligned economics

Cost that scales with completed screenings.

Our model aligns spend to realized utilization, so cost tracks completed screenings and every dollar stays tied to real value. Higher participation lowers cost per completed screening, keeps operations steady, and makes spend predictable. The same infrastructure supports additional screening programs without rebuilding operations, so plans can extend the model to cervical, diabetes, kidney, and more while keeping consistent performance management.

Why health plans partner with SNT Biotech

Complete program execution, from first outreach to follow-up

📦

End-to-end management

From kit assembly through result reporting and follow-up, run as one accountable program.

💬

Omni-channel outreach

SMS, automated calls, live support, and mail, with multilingual, culturally appropriate messaging.

📊

Real-time reporting

Live dashboards and on-demand reporting, with secure data exchange and plan system integration.

🔬

Our own accredited lab

Testing runs through our own high-complexity CLIA and COLA accredited laboratory.

🛡

Certified & compliant

SOC 2 and HITRUST certified, HIPAA aligned, with audit-ready documentation throughout.

🤝

Follow-up built in

Abnormal results are referred for diagnostic follow-up, so screening leads to care.

Download

Get the full PDF case study

The complete case study, including program design, results, clinical impact, and the economics of an at-home FIT program. Tell us where to send it and it is yours.

We respect your inbox. See our privacy policy.

See what a program like this could do for your members.

Request a 30-minute demo and we will model the return for your population.

Request a demo For health plans
Certified & compliant SOC 2HITRUSTHIPAACLIACOLAWBENCNMSDC